KLP Kapitalforvaltning AS Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

KLP Kapitalforvaltning AS acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 311,435 shares of the healthcare conglomerate’s stock, valued at approximately $157,543,000. UnitedHealth Group makes up about 0.7% of KLP Kapitalforvaltning AS’s investment portfolio, making the stock its 17th biggest position.

A number of other institutional investors have also recently made changes to their positions in the business. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on UNH. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Finally, Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 1.3 %

Shares of UnitedHealth Group stock opened at $517.72 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $473.57 billion, a PE ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a 50-day moving average of $510.19 and a two-hundred day moving average of $547.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.